Healing After Augmentation of Alveolar Ridge Using Collagen Membrane
Cellular and Tissue Mechanisms of Bone and Soft Tissue Healing After Augmentation of Alveolar Ridge With Cross-linked Type I Collagen Membrane
1 other identifier
interventional
90
1 country
1
Brief Summary
One of the prerequisites for successful prosthetic implant therapy of patients is achieving the initial stability of the embedded implant, which largely depends on the width alveolar ridge, at the place of its installation. Regenerative therapy of the horizontal dimension of the alveolar ridge simultaneously with the installation of implants is carried out using biocompatible materials; a basket of thin ones substitutes and collagen membranes. Clinical application of the collagen matrix to date has shown successful regeneration soft tissue in corrective surgery of the oral mucosa, by increasing the volume of the gingiva, approximately as effective as the application of a connective tissue graft from the palate. In the current literature, there is no data on the cellular effects of the regeneration of soft, a especially bone tissue, after the application of a membrane with cross-linked collagen type I, u regenerative therapy of fenestrations, dehiscence and buccal contour augmentations bone lamellae, simultaneously with implant placement. Also, tissue monitoring mechanisms of regeneration of soft and bone tissue, has not been shown in the literature so far controlled and systematized results using the Primescan digital program scans and software analysis of soft tissue regeneration parameters, as well as their own correlations with CBCT and clinical analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2025
CompletedFirst Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
March 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2029
March 25, 2025
March 1, 2025
2.7 years
March 13, 2025
March 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Achived volume of the bone after implant placement and augmentation
Assessment and comparative analysis quantity of newly formed bone and soft tissue using CBCT and digital, software analysis
4 years
Study Arms (2)
Implant placement with augmentation
EXPERIMENTALPatients who are indicated for implant rehabilitation. Guided tissue regeneration employs augmentation with cross-linked type I collagen membrane to create different gingiva phenotype. The material will be placed after implantation using the following standard surgical protocols. Collagen membrane will serve as a barrier for epithelial cells and thereby promote bone healing.
Implant placement without augmentation
ACTIVE COMPARATORPatient that needs implant placement in order for functional and aesthetic rehabilitation. Surgical procedures done in this group follow standard surgical protocols for implant placement without regenerative therapy.
Interventions
Late implant placement without regenerative therapy
Application of collagen membrane after implant placement.
Eligibility Criteria
You may qualify if:
- ASA I classification of health status,
- Non-smokers or consumption of up to 10 cigarettes per day,
- No signs of gingival inflammation,
- Late installation of implants,
- The possibility of achieving the primary stability of the implant,
- The dimension of the residual alveolar ridge for implant placement ≥5 mm wide, height ≥12 mm,
- Diagnosed fenestration, dehiscence of buccal bony lamella ≤3 mm in size and/or thickness of buccal bone lamella ≤1.5 mm,
- Plaque index (PI) and gingival bleeding on provocation (KNP) \<15% and probing depth (DS) \<3 mm,
- Preserved cemento-enamel border (CGG) without the presence of non-carious cervical lesions (NCL), or the presence of a defect in the root area up to 1mm deep with preserved CGG,
- Preserved interjaw relationships.
You may not qualify if:
- Systemic acute administration of drugs up to 7 days before surgical intervention,
- Systemic chronic administration of steroids or non-steroidal anti-inflammatory drugs,
- History of oral surgical interventions in the last 4 months,
- Poor oral hygiene,
- Demonstrated hypersensitivity to collagen,
- Pregnancy and breastfeeding,
- Patient withdrawal from the research protocol in any evaluation period,
- Patients who underwent standard augmentation of bone tissue with a substitute for bone and membrane, after implant installation,
- Participation in clinical research in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Sental Medicine
Belgrade, 011, Serbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
March 13, 2025
First Posted
March 20, 2025
Study Start
March 7, 2025
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2029
Last Updated
March 25, 2025
Record last verified: 2025-03